Skip to content
Subscriber Only

Moderna Therapeutics Files for IPO With $500 Million Placeholder

  • Biotech company got $7 billion valuation in funding round
  • IPO filing follows offerings by 75 biotech companies this year

Moderna Therapeutics Inc., a biotechnology company valued at $7 billion in a private funding this year, has filed to go public in the U.S.

The Cambridge, Massachusetts-based company listed the size of its initial public offering as $500 million, typically a placeholder amount used to calculate fees. The company, which plans to list as Moderna Inc., had about 96 million shares outstanding as of Sept. 30, according its filing Friday with the U.S. Securities and Exchange Commission.